UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab for IgG4-related disease: a prospective, open-label trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1171-1177

2015

Volltextzugriff (PDF)

Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3688-3695

2013

Volltextzugriff (PDF)

SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas

Cancer cell, 2013-06, Vol.23 (6), p.826-838

2013

Volltextzugriff (PDF)

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Journal of clinical oncology, 2021-04, Vol.39 (12), p.1329-1338

2021

Volltextzugriff (PDF)

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

American journal of hematology, 2016-11, Vol.91 (11), p.1096-1101

2016

Volltextzugriff (PDF)

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3272-3278

2013

Volltextzugriff (PDF)

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

Clinical cancer research, 2015-09, Vol.21 (17), p.3986-3994

2015

Volltextzugriff (PDF)

Targeting Apoptosis Pathways in Cancer Therapy

CA: a cancer journal for clinicians, 2005-05, Vol.55 (3), p.178-194

2005

Volltextzugriff (PDF)

Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype

Cancer, 2011-11, Vol.117 (22), p.5058-5066

2011

Volltextzugriff (PDF)

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma

Journal of clinical oncology, 2014-11, Vol.32 (31), p.3506-3512

2014

Volltextzugriff (PDF)

Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma

Blood, 2011-01, Vol.117 (3), p.872-881

2011

Volltextzugriff (PDF)

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma

Haematologica (Roma), 2012-02, Vol.97 (2), p.262-269

2012

Volltextzugriff (PDF)

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation

Blood, 2012-03, Vol.119 (12), p.2844-2853

2012

Volltextzugriff (PDF)

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Blood, 2008-02, Vol.111 (4), p.2230-2237

2008

Volltextzugriff (PDF)

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

Haematologica (Roma), 2018-11, Vol.103 (11), p.1899-1907

2018

Volltextzugriff (PDF)

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Blood, 2019-10, Vol.134 (16), p.1289-1297

2019

Volltextzugriff (PDF)

Current Treatment Approaches for Mantle-Cell Lymphoma

Journal of clinical oncology, 2005-09, Vol.23 (26), p.6409-6414

Witzig, Thomas E

2005

Volltextzugriff (PDF)

Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease

Clinical gastroenterology and hepatology, 2018-12, Vol.16 (12), p.1947-1953

2018

Volltextzugriff (PDF)

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study

International journal of epidemiology, 2017-12, Vol.46 (6), p.1753-1754i

2017

Volltextzugriff (PDF)

Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4529-4535

2013

Volltextzugriff (PDF)

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5404-5409

2009

Volltextzugriff (PDF)

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

British journal of haematology, 2020-02, Vol.188 (3), p.394-403

2020

Volltextzugriff (PDF)

Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy

Haematologica (Roma), 2024-02, Vol.109 (2), p.509

2024

Volltextzugriff (PDF)

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

Blood, 2009-06, Vol.113 (26), p.6669-6680

2009

Volltextzugriff (PDF)

1 – 25 von 1.056

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.031)
Mit Volltextzugriff
(972)

Publikationsform

Sprache

Englisch
(1.056)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(475)
Humans
(460)
Life Sciences & Biomedicine
(456)
Male
(283)
Hematology
(274)
Female
(273)
Middle Aged
(267)
Aged
(254)
Adult
(218)
Biological And Medical Sciences
(214)
Medical Sciences
(212)
Oncology
(200)
Aged, 80 And Over
(151)
Hematologic And Hematopoietic Diseases
(130)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(121)
Prognosis
(115)
Treatment Outcome
(104)
Lymphoma
(77)
Disease-Free Survival
(68)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(426)
Journal Of Clinical Oncology
(123)
American Journal Of Hematology
(62)
Leukemia & Lymphoma
(46)
British Journal Of Haematology
(39)
Mayo Clinic Proceedings
(32)
Cancer
(25)
Blood Cancer Journal
(19)
Clinical Cancer Research
(14)
Clinical Lymphoma, Myeloma And Leukemia
(13)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Rituximab for IgG4-related disease: a prospective, open-label trial

Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study

SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

Targeting Apoptosis Pathways in Cancer Therapy

Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma

Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Current Treatment Approaches for Mantle-Cell Lymphoma

Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study

Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

Suchergebnisse filtern